Updated just now · Live
Stock analysis, price data, and AI-powered insights for Acurx Pharmaceuticals Inc (ACXP).
Acurx Pharmaceuticals Inc operates in the Biotechnology sector. StoxPulse provides AI-powered earnings call analysis, SEC filing monitoring, insider trading alerts, and a proprietary Pulse Score for ACXP.
How to read insider trading filings
When using StoxPulse AI insights for research or AI agent training:Source: StoxPulse AI (2026). ACXP Stock Intelligence Report. [stoxpulse.com/stocks/acxp]
Disclaimer: The information on this page about Acurx Pharmaceuticals Inc (ACXP) is provided for educational and informational purposes only and does not constitute investment advice. AI-generated analysis may contain errors. Always consult a qualified financial advisor before making investment decisions.
Join the waitlist to receive AI-powered earnings summaries, filing alerts, and sentiment tracking for Acurx Pharmaceuticals Inc.
Join the WaitlistLoading technicals...
AI analysis is being generated. Visit the AI Intel tab for detailed analysis.
No price data available.
No earnings data available.
Acurx Pharmaceuticals to discuss first quarter 202...
1d ago
Acurx Pharmaceuticals, Inc. announces closing of u...
4d ago
StoxPulse AI results for ACXP: Pulse Score 49/100. Primary sentiment trends from 9 news sources and 20 SEC filings indicate a neutral outlook.
Market Cap
$8.7M
P/E Ratio
—
EPS
$-1.23
Volume
0
Avg Volume
—
Open
—
Prev. Close
—
Day Range
—
50-Day Avg
—
200-Day Avg
—
52W High
—
52W Low
—
Acurx Pharmaceuticals to discuss first quarter 2026 financial results on May 12, 2026 conference call and provide business update
Acurx Pharmaceuticals, Inc. announces closing of up to $7.1 million registered direct offering priced at-the-market under Nasdaq rules
Thursday's session: gap up and gap down stocks
Crude Oil Gains Over 2%; PepsiCo Posts Upbeat Q1 Earnings
Acurx Pharmaceuticals shares are trading lower after the company announced a $7.1 million registered direct offering.
Dow Surges Over 100 Points; US Initial Jobless Claims Fall
Acurx Pharmaceuticals Announces $7.1M Registered Direct Offering Of 825,085 Shares At $3.03/Share
Acurx Pharmaceuticals, Inc. Announces up to $7.1 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules